Edinburgh Vascular Surgical Service, Clinical & Surgical Sciences (Surgery), University of Edinburgh, Scotland, UK.
Eur J Vasc Endovasc Surg. 2010 Mar;39(3):266-70. doi: 10.1016/j.ejvs.2009.12.023. Epub 2010 Jan 13.
There is considerable interest in the role of novel endovascular techniques for the treatment of patients with complex aneurysms who are unsuitable for standard interventions. Knowledge of the natural history of these lesions, as well as other co-morbidities, is required in order that these techniques may be applied correctly in this high-risk group.
This study reviews the outcome of patients deemed to be unfit for surgery following assessment under the Scottish National Thoraco-abdominal aneurysm service (TAAA) service (2002-2008).
Of 216 patients assessed, 89 (41%) patients were considered to be unfit for intervention. The median (interquartile range, IQR) age of patients was 75 (70-80) years and there were 39 men (44%). Median (IQR) aneurysm size was 6 (5.6-7.0) cm. The median (IQR) follow-up time was 12 (7-26) months. There were 49 (55%) deaths during the follow-up period of which 23 (47%) cases were due to ruptured TAAA and 26 (53%) were not aneurysm-related. Comparing patients with aneurysms <6 cm (33 patients) with those aneurysms > or =6 cm (56 patients) there was no difference in aneurysm-related death (p = 0.32) or all-cause mortality (p = 0.147).
Aneurysm-related mortality amongst patients unsuitable for open TAAA surgery is considerable and evolving endovascular techniques may permit intervention in selected patients. However any intervention can only be justified if the patient's life expectancy is sufficient to allow benefit to accrue.
对于不适合标准介入治疗的复杂动脉瘤患者,新型血管内技术的应用具有重要意义。为了正确地将这些技术应用于这一高危人群,需要了解这些病变的自然史以及其他合并症。
本研究回顾了在苏格兰胸主动脉腹主动脉瘤服务(TAAA)评估后被认为不适合手术的患者的结果(2002-2008 年)。
在评估的 216 名患者中,89 名(41%)患者被认为不适合介入治疗。患者的中位(四分位间距,IQR)年龄为 75(70-80)岁,其中 39 名男性(44%)。中位(IQR)动脉瘤大小为 6(5.6-7.0)cm。中位(IQR)随访时间为 12(7-26)个月。在随访期间有 49 名(55%)患者死亡,其中 23 名(47%)患者死于破裂性 TAAA,26 名(53%)与动脉瘤无关。比较动脉瘤<6cm(33 例)与动脉瘤≥6cm(56 例)的患者,动脉瘤相关性死亡(p=0.32)或全因死亡率(p=0.147)无差异。
不适合开放性 TAAA 手术的患者中,与动脉瘤相关的死亡率相当高,不断发展的血管内技术可能允许对选定的患者进行干预。然而,只有在患者的预期寿命足以获得受益的情况下,任何干预才是合理的。